C4 Therapeutics Inc (CCCC) — Financial Flexibility Index
C4 Therapeutics Inc (CCCC) has a Financial Flexibility Index of -0.32x as of March 2026. Free cash flow of $-29.88 Million (operating CF $-29.94 Million minus capex $64.00K) represents 0% of total liabilities ($94.61 Million). Check how aggressively does C4 Therapeutics Inc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
C4 Therapeutics Inc Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for C4 Therapeutics Inc across 8 annual periods. For the full cash flow conversion analysis, see CCCC cash generation efficiency.
Annual Financial Flexibility Index for C4 Therapeutics Inc (2018–2025)
Year-by-year free cash flow to debt coverage for C4 Therapeutics Inc. Explore CCCC debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.96x | $-98.09 Million | $-98.69 Million | $102.49 Million | ▼ -96.8% |
| 2024 | -0.49x | $-64.98 Million | $-65.16 Million | $133.62 Million | ▲ +39.7% |
| 2023 | -0.81x | $-105.13 Million | $-106.84 Million | $130.34 Million | ▼ -13.7% |
| 2022 | -0.71x | $-100.44 Million | $-105.94 Million | $141.61 Million | ▲ +3.0% |
| 2021 | -0.73x | $-85.69 Million | $-86.97 Million | $117.16 Million | ▼ -31.1% |
| 2020 | -0.56x | $-66.60 Million | $-67.25 Million | $119.35 Million | ▼ -325.5% |
| 2019 | 0.25x | $56.96 Million | $55.61 Million | $230.22 Million | ▲ +491.7% |
| 2018 | -0.06x | $-14.29 Million | $-16.98 Million | $226.24 Million | — |